反応 #316574

ord-be184283c48241a29f84db5e9bec6beb

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他The product was purified via Biotage Horizon® (25S, silica, gradient from 5% EtOAc/hexane to 40% EtOAc/hexane)
  2. 2
    その他isolated as a white foam

実験手順

7-Bromo-4-tert-butyl-5-(3-methoxybenzoyl)-4,5-dihydropyrrolo[1,2-a]quinoxaline was prepared from 7-bromo-4-tert-butyl-4,5-dihydropyrrolo[1,2-a]quinoxaline and m-anisoyl chloride according to the procedure of Example 106, Step 2. The product was purified via Biotage Horizon® (25S, silica, gradient from 5% EtOAc/hexane to 40% EtOAc/hexane) and isolated as a white foam. MS (ESI) m/z 439/441 ([M+H]+); HRMS: calcd for C23H23BrN2O2, 438.0943; found (ESI+), 439.10084.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07563793B2uspto-grants-2009_07